Attovia Therapeutics, Inc. Stock Analysis & AI Score
Attovia Therapeutics, Inc. (ATTO) has an ST Score of 56.0 (B-), driven by its Forecast (A) and held back by its Momentum (C-). ATTO last traded at $18.17.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Attovia Therapeutics, Inc. (ATTO) has an ST Score of 56.0 (B-), driven by its Forecast (A) and held back by its Momentum (C-). ATTO last traded at $18.17.
- Strongest
- ForecastA
- Weakest
- MomentumC-
All factor grades
- ForecastA
- ProfitabilityB
- Financial StrengthB
- GrowthC+
- ValuationC
- MomentumC-
Contact
ATTO stock: frequently asked questions
What is ATTO's ST Score?
Attovia Therapeutics, Inc. (ATTO) has an ST Score of 56.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ATTO a buy, hold, or sell?
Our ST Score grades it B- (56.0/100). The ST Score is a data-driven signal, not a recommendation.
What are ATTO's factor grades?
Valuation C, Profitability B, Financial Strength B, Momentum C-, Growth C+, Forecast A.
What is ATTO's valuation grade?
Attovia Therapeutics, Inc. (ATTO) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ATTO's growth grade?
Attovia Therapeutics, Inc. (ATTO) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ATTO's profitability grade?
Attovia Therapeutics, Inc. (ATTO) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ATTO's financial strength grade?
Attovia Therapeutics, Inc. (ATTO) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ATTO?
The average analyst price target for Attovia Therapeutics, Inc. (ATTO) is $45.33, which is +149.5% versus the recent price of $18.17.